Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleCENTENNIAL PERSPECTIVE

The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984–2008

Patrick J. Murphy
Drug Metabolism and Disposition October 2008, 36 (10) 1977-1982; DOI: https://doi.org/10.1124/dmd.108.023226
Patrick J. Murphy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The dramatic changes in drug metabolism research in the last 25 years are well documented in the publications of the American Society for Pharmacology and Experimental Therapeutics (ASPET). New analytical tools combined with modern molecular biological techniques have provided unprecedented access to the workings of the cell. A field that concentrated on only a handful of primary enzymes now has a list of hundreds in its purview. Genetic variation, environmental impact, and molecular diversity have all come under study in attempts to follow the fate of drugs and chemicals. Examples from ASPET journals will be used to illustrate the dramatic advancements in the field.

Footnotes

  • ↵1 John Fenn received the Nobel Prize in 2002. His lecture on the development of the electrospray interface is an excellent overview of this remarkable field (http://nobelprize.org/nobel_prizes/chemistry/laureates/2002/fenn-lecture.html).

  • ↵2 Drag Anders was awarded the 1999 Brodie Award in recognition of his contributions to the field over a 35-year period starting with studies on SKF 525-A inhibition of drug metabolism (Anders and Mannering, 1966).

  • ↵3 Tom Poulos was the recipient of the 2004 Brodie Award. His Brodie lecture provides an excellent history of the crystal structure of P450 and a detailed comparison to nitric oxide synthase (Poulos, 2005).

  • ↵4 Dan Nebert received the Brodie Award in 1986 for his many contributions to the field. His award lecture details how an initial finding of a difference in inducibility between mouse strains led to the discovery of the Ah receptor and shaped his future career (Nebert, 1988).

  • ↵5 Frank Gonzalez, in accepting the 2006 Brodie Award, discussed the progress in our understanding of CYP2E1 and particularly the value of the 2E1 knockout mouse in elaborating the physiological functions of the enzyme (Gonzalez, 2007).

  • ↵6 Eric Johnson, in his acceptance of the 2002 Brodie Award, detailed the wealth of information gained from the crystal structure of CYP2C5 (Johnson, 2003).

  • ↵7 Bettie Sue Siler Masters, who was involved in many of the pioneering studies on this reductase, received the 2000 Brodie Award. A retrospective of her studies of P450 reductase and nitric oxide synthase has been published (Masters, 2005).

  • ↵8 Curt Klaassen was awarded the 2008 Brodie Award in honor of his many outstanding contributions to our understanding of the role of metabolism in toxicity.

  • ↵9 Grant Wilkinson, one of the authors of the fexofenadine study, was a pioneer in pharmacokinetics who passed away in 2006. Grant was an active member of ASPET, and his many contributions to the field are memorialized in an article in Clin Pharmacol Ther (Wood, 2006).

  • Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.

  • doi:10.1124/dmd.108.023226.

  • ABBREVIATIONS: P450, cytochrome P450; HPLC, high-performance liquid chromatography; UPLC, ultra-performance liquid chromatography; GC/MS, gas chromatograph/mass spectrometer; MS/MS, tandem mass spectrometers; LC/NMR, liquid chromatograph/nuclear magnetic resonance; LC/MS, liquid chromatograph/mass spectrometer; CAR, constitutive androstane receptor; PXR, pregnane X receptor.

    • Received July 2, 2008.
    • Accepted July 14, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (10)
Drug Metabolism and Disposition
Vol. 36, Issue 10
1 Oct 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984–2008
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCENTENNIAL PERSPECTIVE

The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984–2008

Patrick J. Murphy
Drug Metabolism and Disposition October 1, 2008, 36 (10) 1977-1982; DOI: https://doi.org/10.1124/dmd.108.023226

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCENTENNIAL PERSPECTIVE

The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984–2008

Patrick J. Murphy
Drug Metabolism and Disposition October 1, 2008, 36 (10) 1977-1982; DOI: https://doi.org/10.1124/dmd.108.023226
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Analytical Technology
    • Reactive Intermediates
    • The P450s
    • Molecular Biology
    • Induction
    • Drug-Drug Interactions
    • Non-P450 Oxidases
    • Phase II Enzymes
    • Transporters
    • Conclusion
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 2, 1959–1983
  • The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 1, 1909–1958
Show more CENTENNIAL PERSPECTIVE

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics